سیویلیکا را در شبکه های اجتماعی دنبال نمایید.

A preliminary report comparing the effect of Asafoetida with oral contraceptive on polycystic ovarian syndrome in a double-blind randomized trial

Publish Year: 1403
Type: Journal paper
Language: English
View: 181

This Paper With 11 Page And PDF Format Ready To Download

Export:

Link to this Paper:

Document National Code:

JR_AJP-14-3_001

Index date: 27 April 2024

A preliminary report comparing the effect of Asafoetida with oral contraceptive on polycystic ovarian syndrome in a double-blind randomized trial abstract

Objective: Polycystic ovarian syndrome (PCOS) is the most common cause of infertility and endocrine disorders in women of childbearing age. In Persian medicine, Ferula assafoetida L. (Asafoetida) was recommended for treating PCOS. The present study was conducted to compare the effect of Asafoetida with oral contraceptive tablets on PCOS patients.Materials and Methods: Patients with PCOS (n=30) were enrolled in a double-blind randomized clinical trial. On Day 5 of the menstrual cycle, patients received two periods of 21-day treatment, with 7 days rest between the two treatments. On a daily basis, half of the patients (n=15) received Asafoetida (1 g), and the rest received low dose oral contraceptive (LD; one tablet). Menstrual status, anthropometric characteristics, hematology and biochemistry parameters, ovarian ultrasound examination and hirsutism were evaluated prior to the initiation of the experiment and 14 days after the end of treatment. The occurrence of menstrual cycles and pregnancy was assessed eight months after the end of treatment.Results: The incidence of pregnancy was greater in patients who received Asafoetida compared to those who received LD (p=0.019). The time intervals between menstrual cycles became shorter in both groups (p<0.05). The occurrence of regular menstrual cycles remained longer in the Asafoetida compared to the LD group (p=0.001). Concentrations of triglycerides, cholesterol, HDL and LDL were significantly increased after treating with LD (p<0.05).Conclusion: In PCOS patients, the occurrence of regular menstrual cycles and the incidence of pregnancy were improved following treatment with Asafoetida. This medicament could be considered a safe treatment for patients with PCOS.

A preliminary report comparing the effect of Asafoetida with oral contraceptive on polycystic ovarian syndrome in a double-blind randomized trial Keywords:

A preliminary report comparing the effect of Asafoetida with oral contraceptive on polycystic ovarian syndrome in a double-blind randomized trial authors

Najmeh Dehparvar

Department of Traditional Persian Medicine, Faculty of Medicine, Shahed University, Tehran, Iran

Ahia Garshasbi

Department of Obstetrics and Gynecology, Medical School, Shahed University, Tehran, Iran

Amir Niasari-Naslaji

Department of Theriogenology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran

Fatemeh Alijaniha

Traditional Medicine Clinical Trial Research Center, Shahed University, Tehran, Iran

Mohammad Gholami-Fesharaki

Department of Biostatistics, Faculty of Medicine, Tarbiat Modares University, Tehran, Iran

Farzaneh Ghaffari

School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Mohsen Naseri

Traditional Medicine Clinical Trial Research Center, Shahed University, Tehran, Iran